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Objectives: To systematically review the measurement properties of performance-based measures to
assess physical function in people with hip and/or knee osteoarthritis (OA).
Methods: Electronic searches were performed in MEDLINE, CINAHL, Embase, and PsycINFO up to the end
of June 2012. Two reviewers independently rated measurement properties using the consensus-based
standards for the selection of health status measurement instrument (COSMIN). “Best evidence
synthesis” was made using COSMIN outcomes and the quality of ﬁndings.
Results: Twenty-four out of 1792 publications were eligible for inclusion. Twenty-one performance-based
measures were evaluated including 15 single-activity measures and six multi-activity measures.
Measurement properties evaluated included internal consistency (three measures), reliability (16
measures), measurement error (14 measures), validity (nine measures), responsiveness (12 measures)
and interpretability (three measures). A positive rating was given to only 16% of possible measurement
ratings. Evidence for the majority of measurement properties of tests reported in the review has yet to be
determined. On balance of the limited evidence, the 40 m self-paced test was the best rated walk test, the
30 s-chair stand test and timed up and go test were the best rated sit to stand tests, and the Stratford
battery, Physical Activity Restrictions and Functional Assessment System were the best rated multi-
activity measures.
Conclusion: Further good quality research investigating measurement properties of performance
measures, including responsiveness and interpretability in people with hip and/or knee OA, is needed.
Consensus on which combination of measures will best assess physical function in people with hip/and
or knee OA is urgently required.
Crown Copyright  2012 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society
International. All rights reserved.Introduction
Measurement of treatment outcomes and change in health
status over time is a critical component of research and clinical
practice for people with osteoarthritis (OA). The Osteoarthritis
Research Society International (OARSI) and Outcome Measures in
Rheumatology and Clinical Trials (OMERACT) jointly advocate the
use of core outcome measures for clinical trials of OA that address
the domains of pain and function1. Currently there is no singularF. Dobson, Centre for Health,
iotherapy, School of Health
treet, Victoria 3010, Australia.
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012 Published by Elsevier Ltd ongold standard for the assessment of physical function. Physical
function is related to “the ability to move around”2 and “the ability
to perform daily activities”3 and can be classiﬁed as Activities using
the World Health Organization International Classiﬁcation of
Functioning, Disability and Health (ICF) model4.
Measurement of physical function is complex as it contains
multi-dimensional constructs3,5. A range of both self-report and
performance-based measures have been used to assess physical
function. Performance-based measures are deﬁned as assessor-
observed measures of tasks classiﬁed as “activities” using the ICF
model4 and are usually assessed by timing, counting or distance
methods. They are not speciﬁc to body structure, body function or
impairments such as measures of muscle strength or range of
motion. Performance-based measures assess what an individual
can do rather thanwhat the individual perceives they can do, which
is determined by self-report measures3. Increasing evidencebehalf of Osteoarthritis Research Society International. All rights reserved.
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construct of function and are more likely to fully characterize
a change in body function than self-reported measures alone6e8.
Both types of measures are now seen as complementary rather
than competing when evaluating functional outcomes in people
with OA5,9,10.
A previous systematic review of performance-based measures
in OA concluded that better designed studies assessing the
measurement properties of these measures in OA populations were
required3. Also, only a small percentage (7%) of measurement
properties were rated as ‘positive’ for the quality of the ﬁndings and
the levels of evidencewere generally unknown or very limited. This
previous review evaluated studies published up until early 2004
and since then further studies have been published. In addition,
a new quality evaluation tool, the consensus-based standards for
the selection of health status measurement instruments (COS-
MIN)11,12 and scoring system13, has been developed to standardize
the assessment of methodological quality of measurement studies.
The aim of this study was to systematically review the
measurement properties of performance-based tests to measure
physical function in people with hip and/or knee OA using a robust
quality evaluation tool and scoring system (COSMIN). Such a review
would be a useful and timely update for researchers and clinicians
to assist them in selecting appropriate clinical performance-based
measures for people with hip and knee OA.
Methodology
Literature search
The search strategy was developed, reviewed and reﬁned by
multiple authors, in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines14.
Electronic searches of entire databases up until June 2012 were
performed using MEDLINE via PubMed, CINAHL via EBSCO, Embase
via Elsevier, and PsycINFO via CSA. Key search terms and synonyms
were searched separately in four main ﬁlters which were then
combined. These ﬁlters are summarized as:
1. Construct: physical function OR physical performance OR
physical activity
2. Target population: Hip OR knee OR lower-limb AND osteoar-
thritis OR arthritis OR OA OR replacement OR arthroplasty
3. Measurement instrument: performance test/measure/instru-
ment/assessment/index OR objective test/measure/assess-
ment/OR observational test/measure/assessment/index OR
task performance and analysis
4. Measurement properties: instrument development OR
psychometrics OR clinimetrics OR validity OR reliability OR
responsiveness OR interpretability OR meaningful change.
The search strategy was based on recommendations for per-
forming systematic reviews of measurement properties15 and is
more fully described in Appendix 1. For MEDLINE (PubMed), we
adopted a measurement properties search ﬁlter shown to retrieve
more than 97% of publications related to measurement proper-
ties16. Targeted hand-searching of reference lists was also
performed.
Eligibility criteria
Studies were screened by two independent reviewers (FD and
MH). This included independent screening of the titles and
abstracts from all retrieved studies followed by independent full-
text review of potentially eligible studies. Any disagreementswere discussed and resolved with a third reviewer (CT). Studies
were included if they met the following criteria:
1. Construct: The test was ameasure of physical function, deﬁned
according to the ICF model as Activities, which relate to the
ability to move around and perform daily activities4. If the test
was a battery of multi-task items, then at least 80% of the items
were required to assess activities.
2. Target population: The study population comprised at least
80% of people diagnosed with symptomatic hip or knee OA
using clinical or radiographic criteria. This could include all
stages of disease as well as individuals who had recently
undergone a speciﬁc intervention such as joint arthroplasty or
an exercise program, where measures pre-intervention were
provided.
3. Measurement instrument: The measure under study should
be a performance-based measure which is evaluated by an
observer as the activity is being performed by the individual,
usually by timing, counting or distance methods.
4. Setting: The measure was conducted within the clinic or ﬁeld
and required non-technical, readily available, inexpensive and
portable equipment.
5. Measurement properties: The study aim was to evaluate one
or more measurement properties (e.g., internal consistency,
reliability, validity, responsiveness and/or interpretability).
6. Full-text studies published as original articles.
Studies were excluded if: (1) the focus was on validating self-
reported measures of function; (2) the measure predominately
targeted the ICF level of impairment or health related quality of life;
(3) treatment effectiveness was evaluated without a speciﬁc aim to
study the measurement properties of performance measures; (4)
the measure required expensive sophisticated equipment such as
three-dimensional gait analysis or accelerometers; (5) they were
published only as ‘grey literature’ such as scientiﬁc meeting
abstracts, dissertations or unpublished literature; and (6) theywere
published in languages other than English due to limited language
translational ability.
Methodological quality evaluation of the studies
The COSMIN tool was used to evaluate the methodological
quality of included studies11,17. Two raters (FD and MH) with prior
COSMIN tool experience assessed the quality of all included studies
independently using the four-point scored COSMIN checklist13. This
standardized and validated tool consists of 10 sections, each
assessing a different measurement property: internal consistency,
reliability, measurement error, content validity, construct validity
(structural validity and hypothesis testing), cross-cultural validity,
criterion validity, responsiveness and interpretability. Each section
contains between 5 and 18 items.
Each item within a section is scored using a four-point scoring
systemwith deﬁned response options representing excellent, good,
fair or poor quality13. An overall quality score for each measure-
ment property reported in a study is deﬁned as the lowest rating of
any item within that section, i.e., “worst score counts” method.
Depending on the number of measurement properties assessed in
a study, some studies receive one quality evaluation whereas other
studies receive several.
Evaluation of the measurement property result
In addition to amethodological quality evaluationwith COSMIN,
an overall rating of the study ﬁndings for each measurement
property was assessed using a commonly used checklist of criteria
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tive, indeterminate and negative ratings for the study ﬁndings and
are deﬁned in Table I.
Best evidence synthesis: levels of evidence
To synthesize the results from multiple studies on the same
performance test, “a best evidence synthesis”15 was performed by
the ﬁrst author using the criteria outlined in Appendix 2. This best
synthesis of evidence is similar to that used for synthesizing
evidence from clinical trials19. The possible levels of evidence for
a measurement property are “strong”, “moderate”, “limited”
“conﬂicting” or “unknown” (Appendix 2). Best evidence synthesis
was derived using the methodological quality of the studies (COS-
MIN score), the rating and consistency of the measurement prop-
erty result (positive, indeterminate, negative e Table I), as well as
the number of related studies evaluating each measurement
property. For this review, studies could only be considered related
when the same variation of the performance-based measure was
evaluated, that is they were comparable in regards to activity and
procedure. Measurement properties from studies that were rated
as “poor” on the COSMIN were not eligible to contribute to best
evidence synthesis15.
The COSMIN scoring system used in this review was initially
developed for assessing psychometric properties in self-reported
questionnaires and deﬁnes a minimum adequate sample size as
30 (fair), and adequate sample size as 100 (excellent). It was antic-
ipated that many studies, particularly those evaluating reliability
andmeasurement error, were likely to contain smaller sample sizesTable I
Quality criteria for rating the results of measurement properties
Property Rating Quality criteria
Reliability
Internal consistency þ Cronbach’s alpha(s) 0.70
? Cronbach’s alpha not determined
 Cronbach’s alpha(s) <0.70
Reliability þ ICC/weighted kappa 0.70 OR Pearson’s r 
? Neither ICC/weighted kappa, nor Pearson’s r
 ICC/weighted kappa <0.70 OR Pearson’s r <
Measurement error þ MIC >SDC OR MIC outside the LOA
? MIC not deﬁned
 MIC SDC OR MIC equals or inside LOA
Validity
Content validity þ The target population considers all items in t
? No target population involvement
 The target population considers items in the
Structural validity þ Factors should explain at least 50% of the var
? Explained variance not mentioned
 Factors explain <50% of the variance
Construct validity
hypothesis testing
þ Correlation with an instrument measuring th
hypotheses AND correlation with related con
? Solely correlations determined with unrelate
 Correlation with an instrument measuring th
hypotheses OR correlation with related cons
Cross-cultural validity þ Original factor structure conﬁrmed OR no im
? Conﬁrmatory factor analysis not applied and
 Original factor structure not conﬁrmed OR im
Criterion validity þ Convincing arguments that gold standard is
? No convincing arguments that gold standard
 Correlation with gold standard <0.70, despit
Responsiveness
Responsiveness þ Correlation with an instrument measuring th
hypotheses OR AUC 0.70 AND correlation w
? Solely correlations determined with unrelate
 Correlation with an instrument measuring th
hypotheses OR AUC <0.70 OR correlation wi
SDC, smallest detectable change; LoA, limits of agreement; DIF, differential item functio
Adapted from Terwee et al. J Clin Epidemiol 2007;60(1):34e42.than those recommended for self-reported questionnaires. Based
on discussions with the developers of the COSMIN, it was decided
that to avoid the exclusion of many small samples (which might
otherwise be of excellent/good quality) from best evidence
synthesis, the sample size item was removed from the COSMIN
quality assessment and the “second worst score counts” method
was used. Sample size was then accounted for at the evidence
synthesis stage. Evidence was assigned as: “strong” when the total
sample size of eligible combined studies was 100; “moderate”
with total samples between 50 and 99; “limited”with total samples
between 25 and 49, and “unknown” with samples less than 25.
Results
Description of included studies and performance-based measures
Selection procedures are summarized in Fig. 1. Twenty-four
eligible studies were identiﬁed and are described in Table II.
Measurement properties from 15 single-activity measures were
investigated in 12 studies6,20e30 and from six multi-activity
measures investigated in 12 studies7,8,10,31e39. Single-activity
measures could be grouped into three main activity domains: (1)
walking tests, (2) sit to stand tests, and (3) stair negotiation tests.
There were two main types of walk tests, those over short
distances (<100 m) and those over long distances (>100 m). There
were nine different short-distance walk tests with variations in (1)
set pace (self-paced, fast-paced); (2) distance walked (range 2.4e
80 m); (3) functional measure (time, speed, distance, quality
grading); and (4) incorporated turns (range 0e7). Short-distance0.80
determined
0.80
he questionnaire to be relevant AND considers the questionnaire to be complete
questionnaire to be irrelevant OR considers the questionnaire to be incomplete
iance
e same construct 0.50 OR at least 75% of the results are in accordance with the
structs is higher than with unrelated constructs
d constructs
e same construct <0.50 OR <75% of the results are in accordance with the
tructs is lower than with unrelated constructs
portant DIF between language versions
DIF not assessed
portant DIF found between language versions
“gold” AND correlation with gold standard 0.70
is “gold” OR doubtful design or method
e adequate design and method
e same construct 0.50 OR at least 75% of the results are in accordance with the
ith related constructs is higher than with unrelated constructs
d constructs
e same construct <0.50 OR <75% of the results are in accordance with the
th related constructs is lower than with unrelated constructs
ning; þ, positive rating; ?, indeterminate rating; , negative rating.
Fig. 1. Flowchart of the selection and inclusion of studies.
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34,36e39. The 6-min walk test was the only long-distance walk test
and was investigated in four studies6,22,26,28 and included in two
multi-activity measures8,10,35.
There were six different sit to stand tests with variations in (1)
method of measurement (count over 30 s, time for ﬁve repetitions,
total time and quality grading) and (2) height of chair (standard and
high) and (3) incorporated walking and/or turning components
(timed up and go test, which incorporates walking 3 m, turning and
returning to sit down and the get up and go test, which incorpo-
rates walking 20 mwith no return). Sit to stand tests were included
in three multi-activity measures7,8,10,31e34.
There were seven different stair negotiation tests with varia-
tions in (1) number of stairs (range 4e12); (2) ascend only, descend
only or both; (3) hand-rail support and (4) leading limb step
pattern. Stair negotiation tests were included in ﬁve/six multi-
activity measures7,8,10,31e36.
Three studies included participants with hip OA24,30,32, ﬁve with knee
OA6,20,22,26,27 and16with bothhip andkneeOA7,8,10,21,23,25,28,29,31,33e39. The
majorityof studies includedparticipants in theendstageofOAor thestage
of diseasewas not speciﬁed.Measurement properties
The inter-rater agreement of the independent methodological
quality of included studies was good [absolute agreement ¼ 90%,
kappa ¼ 0.85, 95% conﬁdence interval (CI) 0.72, 0.98]. Disagree-
ment was mainly due to reading errors and was easily resolved
using a consensus method between the two raters.
Internal consistency
Internal consistency was only applicable to multi-activity
measures and was assessed in three measures31,35,37 (Table III).
Two studies were rated as “excellent” quality35,37. A positive
internal consistency rating (a ¼ 0.82 and 0.84) was found in both
studies.
Reliability and measurement error
Reliability was assessed in 16/21 of the performance measures.
Measurement error was assessed in 14/21 of the performance
measures (Table III).
Table II
Characteristics of included studies
Author (Year) Mean age years  SD (range) OA site OA stage Performance
measure
Activity No. of PPMs No. of scores Equipment
required
Measurement property
assessed
Single-activity measures
French (2011)22 65.3  6.9 Knee NS TUG
CST
6MWT
Stand, 3 m walk, turn, return, sit
Chair-rise  ﬁve reps
6 min walking
3 3 Chair, stopwatch
walking space
Responsiveness
Gill (2008)23 70.3  9.8 Hip/knee ES/PA WT
CST
Walk 50-feet (15.2 m) fast-paced
Chair-rise over 30 s
2 5 20 m walkway
Chair, stopwatch
Testeretest reliability
Inter-reliability
Measurement error
Mizner (2011)6 65.0  9.0 Knee ES/PA TUG
SCT
6MWT
Stand, 3 m walk, turn, return, sit
Up and down 12 stairs
6 min walking
3 3 Chair, stopwatch
Stairs,
Walking space
Responsiveness
Construct validity
Wright (2011)30 66.5  9.4 Hip NS TUG
WT
CST
Stand, 3 m walk, turn, return, sit
Walk 4  10 m self-paced
Chair-rise over 30 s
4 4 Chair, stopwatch
20 cm step
10 m walkway
Interpretability
Inter-reliability
Measurement error
Hoeksma (2003)24 72.0  6.0 Hip Early-late
K&L 0-IV
WT Walk 80 m fast-paced 15 m walkway
Stopwatch
Responsiveness
Borjesson (2007)20 63.0  5.0 Knee ES/PA WT Walk 5 m slow-paced
Walk 5 m medium-paced
Walk 5 m fast-paced
3 3 <10 m walkway
Stopwatch
Responsiveness
Kennedy (2005)28 63.7  10.7 Hip/knee ES/PA WT
SCT
TUG
6MWT
Walk 2  20 m fast-paced
Up and down nine stairs
Stand, 3 m walk, turn, return, sit
6 min walking
4 4 Chair, stopwatch
>20 m walkway
Nine-step stairs
Walking space
Testeretest reliability
Measurement error
Responsiveness
Parent (2002)26 68.6  8.7 Knee ES/PA 6MWT 6 min walking 1 1 Walking space
Stopwatch
Responsiveness
Davey (2003)21 69.5  7.2 Hip/knee NS WT
SCT
Walk eight feet self-paced
Up and down four stairs
2 2 <5 m walkway
Four-step stairs
Testeretest reliability
Measurement error
Piva (2004)27 62.0  9.0 Knee Mid-late
K&L > 2
GUG Stand, walk 20 m, no return 1 1 Chair with arms
20 m walkway
15.2 mark
Stopwatch
Intra-/inter-reliability
Measurement error
Construct validity
Marks (1994a)25 65.9  8.3 Knee NS WT Walk 13 m self-paced 1 1 13 m walkway
Stopwatch
Testeretest reliability
Measurement error
Marks (1994b)29 59.2  11.1 Knee NS WT Walk 13 m self-paced 1 1 13 m walkway
Stopwatch
Testeretest reliability
Measurement error
Responsiveness
Multi-activity measures
Oberg (1994)33 69.0  9.0 Hip/knee Early-Mid FAS Rise from half stand max no.
Sit to stand lowest height
Step (max height)
Stand one leg
Stair climbing (NS)
Gait speed over 65 m
Walking aid
7 1 Adj height chair
Adj height step
Stopwatch
65 m walkway
Stairs
Inter-reliability
Structural validity
Oberg (1997)34 68.9  9.7 Hip/knee Early-Mid FAS Rise from half stand max no.
Sit to stand lowest height
Step (max height)
Stand one leg
Stair climbing (NS)
Gait speed over 65 m
Walking aid
7 1 Adj height chair
Adj height step
Stopwatch
65 m walkway
Stairs
Criterion validity
Nilsdotter (2001)32 72.6 (52e86) Hip ES/PA
K&L > 2
FAS Rise from half stand max no.
Sit to stand lowest height
Step (max height)
Stand one leg
Stair climbing (NS)
7 1 Adj height chair
Adj height step
Stopwatch
65 m walkway
Stairs
Responsiveness
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Gait speed over 65 m
Walking aid
McCarthy (2004)36 64.7  9.8 Knee NS ALF 8 m walk test
Seven step SCT up and down
Sit transfer test
3 1 10 m space
Seven-step stair
Chair (no arms)
Stopwatch
Testeretest reliability
Measurement error
Construct validity
Responsiveness
Rejeski (1995)35 68.8  5.6 Knee NS PAR 6MWT
Five or nine-step SCT up and down
Lift þ carry timed
In/out car timed
4 1 Walking space
Five or nine-step stair
Movable shelves
2.2 kg weight
Mock up car
Internal consistency
Testeretest reliability
Convergent validity
Concurrent validity
Lin (2001)31 69.4  5.9 Hip/knee NS Lin Battery Eight feet walk test
Four-step SCT ascend
Four-step SCT descend
CST x5
4 1 3 m space
Four-step stair
Chair
Stopwatch
Testeretest reliability
Measurement error
Floor/ceiling
Internal consistency
Construct validity
Steultjens (1999)37 68.0  8.9 Hip/knee NS Steultjens Walk 1 min self-paced
Sitting down timed
Lying down timed
Bend þ lift timed
4 1 8 m space
Chair
Bench
2 kg weight
Stopwatch video
Trained observer
Internal consistency
Construct validity
Steultjens (2000)38 68.0  8.9 Hip/knee NS Steultjens Walk 1 min self-paced
Sitting down timed
Lying down timed
Bend þ lift timed
4 1 8 m space
Chair
Bench
2 kg weight
Stopwatch video
Trained observer
Construct validity
Steultjens (2001)39 67.9  8.7 Hip/knee NS Steultjens Walk 1 min self-paced
Sitting down timed
Lying down timed
Bend þ lift timed
4 1 8 m space
Chair
Bench
2 kg weight
Stopwatch video
Trained observer
Responsiveness
Stratford (2006a)8 65 (58e72)
(1e3 QR)
Hip/knee ES/PA WT
TUG
SCT
6MWT
Walk 2  20m fast-paced
Stand, 3 m walk, turn, return, sit
Up and down nine stairs
6 min walking
4 1 >20 m space
Chair
Nine-step stair
Walkway
Construct validity
Stratford (2006b)10 65.0 (55e77) Hip/knee ES/PA WT
TUG
SCT
6MWT
Walk 2  20 m fast-paced
Stand, 3 m walk, turn, return, sit
Up and down nine stairs
6 min walking
4 1 >20 m space
Chair
Nine-step stairs
Stopwatch
Construct validity
Stratford (2009)7 61.7  10.7 Hip/knee K&L > 2
ES/PA
WT
SCT
TUG
Walk 2  20 m fast-paced
Up and down nine stairs
Stand, 3 m walk, turn, return, sit
3 1 >20 m space,
Nine-step stair
Chair
Stopwatch
Construct validity
6MWT, 6-min walk test; CST, chair stand test; ES/PA, end stage/post arthroplasty, FAS, functional assessment system; GUG, get up & go test; K&L, Kellgren and Lawrence classiﬁcation; SCT, stair-climb test; TUG, timed up & go
test; WT, walk test.
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Table III
Measurement properties of performance-based measures (reliability and measurement error)
Performance-based
measure
Internal consistency Reliability Measurement error
Result Study n COSMIN score Result Design Time interval Study n COSMIN score Result Study n COSMIN score
Walk tests
50ft fast-paced23 N/A ICC1,1 0.91e0.97 (0.86e0.98)
ICC1,1 0.94e0.97 (0.90, 0.98)
Intra-rater
Inter-rater
Intra-session
Intra-session
35e47
28e31
Fair
Fair*
SEM 1.32 s
MDC90 3.08 s
81 Fair
40 m self-paced30 N/A ICC2,1 0.95 (0.90, 0.98) Inter-rater <1 week 29 Good* SEM 1.0 m/s 29 Good*
80 m fast-paced24 N/A e e
40 m fast-paced28 N/A ICC2,1 0.91 (0.81, 0.97) Testeretest Mean 25.4 weeks 21 Fair* SEM 1.73 s
(CI 1.39, 2.29)MDC90 4.04 s
17 Fair*
8 ft self-paced21 N/A Pearson r 0.92 Testeretest <1 week 21 Fair* SEM 0.12 s 21 Fair*
13 m self-paced25,29 N/A ICC1,1 0.83 Testeretest 6 weeks 10 Good* SEM 1.5 s 10 Poor
5 m multi-paced20 N/A e e
6MWT22 N/A e e
6MWT28 N/A ICC2,1 0.94 (0.88, 0.98) Testeretest Mean 25.4 weeks 21 Fair* SEM: 26.29 m
(CI 21.14, 34.77)
17 Fair*
6MWT6 N/A e e
6MWT26 N/A e e
CST
x5 chair stand22 N/A e e
30 s-chair stand23 N/A ICC1,1 0.97e0.98 (0.94, 0.99)
ICC1,1 0.93e0.98 (0.87, 0.99)
Intra-rater
Inter-rater
Intra-session
Intra-session
37e47
28e42
Fair
Fair*
SEM 0.7 stands
MDC90 1.64 stands
40 Fair
30 s-chair stand30 N/A ICC2,1 0.81 (0.63, 0.91) Inter-rater <1 week 29 Good* SEM 1.27 stands 29 Good*
TUG22 N/A e e
TUG6 N/A e e
TUG30 N/A ICC2,1 0.87 (0.74, 0.94) Inter-rater <1 week 29 Good* SEM 0.84 s 29 Good*
TUG28 N/A ICC2,1 0.75 (0.51, 0.89) Testeretest Mean 25.4 weeks 21 Fair* SEM 1.07 s (0.86, 1.41) 17 Fair*
GUG27 N/A ICC 0.95 (0.72e0.98) Intra-rater 2 min 25 Poor SEM 0.55 s, MDC 1.5 s 25 Poor
ICC 0.98 (0.94e0.99) Inter-rater 2 min 25 Good* SEM 0.42 s, MDC 1.2 s 25 Good*
SCTs
12-stair up/down6 N/A e e
Nine-stair up/down28 N/A ICC2,1 0.90 (0.79, 0.96) Testeretest Mean 25.4 weeks 21 Fair* SEM 2.35 s (1.89, 3.10) 17 Fair*
Four-stair up/down21 N/A Pearson r 0.92 Testeretest <1 week 21 Fair* SEM 0.23 s
Multi-activity tests
Lin battery31 a ¼ 0.84 106 Poor ICC 0.94e0.96 (0.75e0.99) Testeretest N/S 10 Fair* SEM 0.10e1.44 s 10 Good*
PAR35 a ¼ 0.82 203 Excellent r ¼ 0.88e0.93 (range of all tests) Testeretest 2 weeks 25 Fair* e
r ¼ 0.72e0.86 (range of all tests) Testeretest 3 months 148 Fair*
ALF36 e ICC 0.99 (0.98e0.99) total ALF Testeretest 1 week 15 Good* SEM 0.86 s 15 Good*
Steultjens battery37e39 a ¼ 0.84 198 Excellent e e
Stratford battery7,8,10 N/A e e
FAS33 e G ¼ 0.99e1.0 (range of all tests) Inter-tester ? 42 Fair e
N/A, not applicable for single-activity tests or multi-activity tests using reﬂective models; FAS, functional assessment system; G, GoodmaneKruskal gamma; MDC, minimal detectable change.
* Denotes a change of COSMIN score after to removal of sample size item from the rating.
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For walking tests, a positive rating [i.e., intraclass correlation
coefﬁcient (ICC)> 0.70] for intra-rater reliability [ICC 0.91e0.97 (CI:
0.86e0.98)] and inter-rater reliability [ICC 0.94e0.97 (CI: 0.90,
0.98)] was reported for the 50ft (15.2 m)-walk test in one “fair”
quality study of hip and knee OA23. A positive rating for inter-rater
reliability [ICC 0.95 (CI: 0.90, 0.98)] was also reported for the 40 m-
walk test in one “good” quality study of hip OA30. For sit to stand
tests, a positive rating for inter-tester reliability [ICC 0.87 (CI: 0.74,
0.94)] was reported for the timed up and go test in one “good”
study of hip OA30. The 30 s-chair stand test was also found to have
a positive rating for intra-tester [ICC 0.97e0.98 (CI: 0.94, 0.99)] and
inter-tester [ICC 0.93e0.98 (CI: 0.87, 0.99)] reliability in a “fair”
study of hip and knee OA23 and inter-tester [ICC 0.81 (CI: 0.63,
0.91)] reliability in a “good” study of hip OA30. Evidence for stair
negotiation tests and other single-activity measures was limited by
small total sample sizes or inappropriate time intervals between
repeat testing.
The standard error of measurement (SEM), alongwithminimum
important change (MIC) was reported in only three of the 12 single-
activity measures (40 m-walk test, timed and 30 s-chair stand
test)30. Measurement error and MIC was deﬁned in one “good”
quality study for the 40 m-walk test (SEM 1.0 m/s; MIC 2.0 m/s),
timed up and go test (SEM 0.84 s; MIC 0.8e1.4) and the 30 s-chair
stand test (SEM 1.27 stands; MIC 2.0e2.6 stands)30. As MIC was not
calculated for the remaining single-activities, quality ratings were
indeterminate for these measures.
Multi-activity measures
Reliability ofmulti-activitymeasureswas reported in three “fair”
quality studies31,33,35 and one “good” quality study36. A positive
rating for testerest reliability was reported for the Physical Activity
Restrictions (PAR) (ICC 0.72e0.86)35. A positive rating for inter-
tester rating (GoodmaneKruskal Gamma 0.99e1.0) was found for
the Functional Assessment System (FAS)33. Evidence of reliability for
other test batteries was limited due to inadequate total sample size.
Measurement error was reported in two test batteries31,36
however as MIC has not been calculated for either battery, quality
ratings were indeterminate.
Validity studies
Validity was assessed in 9/21 (43%) of performance tests
(Table IV).
Single-activity measures
Construct validity was investigated for three single-activity
performance measures6,27. In one “good” quality study, a positive
rating of construct validity was found for the timed up and go test
and the 12-step stair-climb test as more than 75% of the results
were in accordancewith the hypotheses6. In another “good” quality
study a negative rating of construct validity was found for the get
up and go test as less than 75% of the results were in accordance
with the hypotheses27.
Multi-activity measures
Validity was investigated in all six multi-activity batteries and
four were rated as “good” quality for construct validity7,8,10,35,37,38
and one was rated as “fair” quality for criterion and structural val-
idity34. The PAR35 demonstratedmostly positive convergent validity
with treadmill time, VO2 peak and strength and divergent validity
with self-reported dysfunction as predicted. The Steultjens battery38
demonstrated a negative convergent validity with self-reported
mobility and joint range of motion. The Stratford battery demon-
strated positive construct validity in two “good” quality studies andone “fair” study7,8,10. The FAS demonstrated positive structural val-
idity in one “fair” quality study33 and positive criterion validity with
good sensitivity (0.70e0.89) and speciﬁcity (0.57e1.0)34.
Responsiveness
Single-activity measures
Responsiveness was reported in 12/15 single-activity measures
(Table IV). Responsiveness of walking tests was reported in four
“fair” quality studies following either physiotherapy/exercise24,30
or joint arthroplasty20,28. A positive rating [i.e., area under the
curve (AUC) > 0.70] was reported for the 40 m-walk test
(AUC ¼ 0.89)30 and the 80 m-walk test (AUC ¼ 0.71)24. Respon-
siveness of other walk tests was reported using standard response
means (SRM) or effect sizes (ES) (see Table IV) and results were
therefore indeterminate. Responsiveness of sit to stand tests was
reported in three “fair” quality studies following either physio-
therapy30 or joint arthroplasty6,28. A positive rating was reported
for the 30 s-chair stand test (AUC ¼ 0.73) and a negative rating
(AUC < 0.70) was reported for the timed up and go test
(AUC ¼ 0.69) following physiotherapy/exercise30. Responsiveness
of other sit to stand tests following joint arthroplasty6,28 and all
stair negotiation tests6,28 was reported using ES and/or SRM and
therefore results were indeterminate.
Multi-activity measures
Responsiveness was reported in three/six multi-activity
measures following either exercise36,39 or hip arthroplasty32. One
study was “good” quality39 and the others were “fair”32,36. A
negative rating of responsiveness of the Steultjens battery39 was
found as <75% of the results were in accordance with the hypoth-
eses. Other batteries provided SRM and results were indeterminate.
Interpretability
Evidence of interpretability was reported in one “good” quality
study that evaluated three single-activity measures30. Major clini-
cally important improvement (MCII) of the 40 m self-paced walk
test (0.2e0.3 m/s), 30 s-chair stand test (2.0e2.6 stands) and the
timed up and go test (0.8e1.4 s), were reported30.
Best evidence synthesis: levels of evidence
A summary of best evidence synthesis for each of the 21
performance tests is provided in Table V. This synthesis was derived
from information found in Tables III and IV including (1) the
methodological quality (COSMIN), (2) the ﬁndings (result), and (3)
the sample size. Given the large variety of performance-based
measures, results were rarely combined. The exceptions were for
the Steultjens battery and the Stratford battery. A positive rating
(limited, moderate or strong evidence) was given to only 25/153
(16%) of all possible ratings.
Discussion
In this systematic review we identiﬁed 24 eligible studies that
reported the measurement properties of 21 different performance-
based measures of physical function in individuals with hip and/or
knee OA. The majority of studies were rated as “fair” quality using
the modiﬁed COSMIN tool. Evidence for most measurement prop-
erties is yet to be determined either because there was no infor-
mation available, information was indeterminate or because
evidence was only available from poor quality studies. Studies were
mostly rated as poor quality due to unclear hypotheses and/or non-
optimal analyses. Although none of the measures included in the
Table IV
Measurement properties of performance-based measures (validity, responsiveness and interpretability)
Performance-based
measure
Validity (hypothesis testing) Responsiveness Interpretability
Design Result Study n COSMIN
score
Treatment Result COSMIN
score
Result COSMIN
score
Walk tests e
50ft fast-paced23 e e
40 m self-paced30 e PT x9 sessions AUC 0.89 (0.76, 1.00) Fair MCII 0.2e0.3 m/s Good
80 m fast-paced24 e PT x9 sessions AUC 0.71 (0.58, 0.83)
GRI 0.45
Fair
40 m fast-paced28 e Hip/knee arthroplasty SRM 0.89 (1.42, 0.68)
pre-ﬁrst post; SRM 0.79
(0.66, 1.45) ﬁrst-second post
Fair
8ft self-paced21 e e
13 m self-paced (29) e Quads exercise (6 weeks) r ¼ 0.9 with quads strength Poor
5 m multi-paced20 e Knee arthroplasty ES/SRM/RE at slow speed:
0.58/0.71/1.62
Fair
6MWT22 e PT mean 5.8 sessions ES/ES med/SRM 0.39/0.43/0.54 Poor
6MWT28 e Hip/knee arthroplasty SRM pre-post1: 1.74 (1.60, 1.97)
SRM post1-post2: 1.90 (1.46, 2.39)
Fair
6MWT6 e
6MWT26 e Knee arthroplasty  PT SRM/ES: pre-2 mth post 0.63/0.41
2e4 mth post 1.51/0.82 pre-4 mth
post 0.58/0.35
Fair
CST
x5 chair stand22 e PT mean 5.8 sessions ES/Es med/SRM
0.36, 0.33, 0.39
Poor
30 s-chair stand23 e e
30 s-chair stand30 e PT x9 sessions AUC 0.73 (0.55, 0.91) Fair MCII 2.0e2.6
stands
Good
TUG22 e PT mean 5.8 sessions ES/ES med/SRM
0.33/0.17/0.35
Poor
TUG6 Construct Low correlations with PROs as
predicted; r ¼ 0.40 to 0.48 with
quads strength as predicted
100 Good Knee arthroplasty ES pre-1 mth/pre-12 mth
/1-12 mth: 0.43, 0.79, 1.17
Fair
TUG30 e PT x9 sessions AUC 0.69 (0.48, 0.90) Fair MCII 0.8e1.4 s Good
TUG28 e Hip/knee arthroplasty SRM pre-post1: 1.08
(1.38, 0.92)
SRM post1epost2:
1.04 (0.84, 1.61)
Fair
GUG27 Construct
Divergent
Sig diff b/w patients and controls P < 0.001 50 Fair e
Convergent r ¼ 0.39; 0.44; 0.34 with WOMAC/
SF-36 PF/ADLS correlation with related
constructs higher than unrelated <75% of
results in accordance with hypothesis
105 Good e
SCTs
12-stair up/down6 Construct Poor correlation with PROs as
predicted; r ¼ 0.36 to 0.46 with
quads strength as predicted
100 Good Knee arthroplasty ES pre-1 mth/pre-12 mth
/1-12 mth:0.71, 0.84, 1.26
Fair
Nine-stair up/down28 e Hip/knee arthroplasty SRM pre-post1:
1.74 (2.13, 1.45)
Fair
SRM post1epost2:
1.98 (1.68, 2.42)
Four-stair up/down21 e e
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Multi-activity tests
Lin battery31 Construct r ¼ 0.48e0.54 with WOMAC-PF 106 Poor e
PAR35 Construct
Convergent
0.30e0.60 Treadmill time, VO2 peak
quads strength
104e437 Good e
Divergent 0.03e0.93 self-reported dysfunction 104e437
ALF36 Construct r ¼ 0.59/0.53 with WOMAC/SF-36PF 214 Poor Exercise program SRM 0.49 at 12 months f/u
Steultjens battery37e39 Construct r ¼ 0.29e0.55 with self-rated mobility 198 Fair Exercise program No differential responsiveness
of observed vs self-report
r ¼ 0.25e0.35 with ROM 198 Good Different factor structure
than expected
Stratford battery7,8,10 Construct SPWT, TUG, 6MWT best combination
to evaluate
177 Fair e
Pain and performance
Construct Change in pain rather than performance
(time/distance) is principal determinant
of change in self-reported function
85 Good e
Construct ANOVA P < 0.001: 73 Good e
PB was more sensitive to change than
SR measures
FAS32e34 Structural PCA-5 factors loading with physical
disability primarily 1 factor explaining
51e82% of variance
105 Fair Hip arthroplasty SRM of mean score ¼ 0.4
at 3 months post-op
SRM of mean score ¼ 0.7
at 6 months post-op
Construct PPMs were better able to discriminate
btw healthy and OA and btw hip and
knee OA P < 0.001 delta 0.67e0.93
Criterion Sensitivity 0.70e0.89
Speciﬁcity 0.57e1.0
(SPWT and SCT had best sensitivity
and speciﬁcity)
Controls 42
Hip OA 302
Knee OA 258
Fair
ADLS, activities of daily living; ANOVA, analysis of variance; ES, effect size index; ES med, effect size median; FAS, functional assessment system; GRI, Gyatts responsiveness index; PCA, principal component analysis; PB,
performance battery; PPM, physical performance measure; PRO, patient-reported outcome; PT, physiotherapy; ROM, range of movement; SF-36 PF, short-form health survey physical function; SPWT, self-paced walk test;
WOMAC, Western Ontario and McMaster Universities Arthritis Index.
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Table V
Levels of evidence of performance-based measures
Performance-based measure Internal consistency Reliability Measurement error Validity Responsiveness Interpretability
Intra Inter Retest
Single-activity measures
Walk tests
50ft fast-paced23 N/A þ(HK) þ(HK) 0 ? 0 0 0
40 m self-paced30 N/A 0 þ(H) 0 þ(H) 0 þ(H)* þþ(H)
80 m fast-paced24 N/A 0 0 0 0 0 þ(H)* 0
13 m self-paced25,29 N/A 0 0 ? ? 0 0 0
8ft self-paced21 N/A 0 0 ? ? 0 0 0
40 m fast-paced28 N/A 0 0 ? ? 0 ? 0
5 m-slow/medium/fast20 N/A 0 0 0 0 0 ? 0
6-min6,22,26,28 N/A 0 0 ? ? 0 ? 0
Sit to stand tests
30 s-chair stand23,30 N/A þ(HK) þ(HK) 0 þ(H) 0 þ(H)* þþ(H)
X5 chair stand22 N/A 0 0 ? ? 0 ? 0
Timed up and go6,22,30 N/A 0 þ(H) ? þ(H) þþ(K) (H)* þþ(H)
Get up and go27 N/A ? 0 ? ? (K) 0 0
Stair negotiation tests
12-stair up and down6 N/A 0 0 0 0 þþ(K) ? 0
Nine-stair up and down28 N/A 0 0 ? ? 0 ? 0
Four-stair up and down21 N/A 0 0 ? ? 0 0 0
Multi-activity measures
Lin31 ? 0 0 ? ? ? 0 0
PAR35 þþþ(K) 0 0 þ(K) 0 þþ(K) 0 0
ALF36 0 0 0 ? ? ? ? 0
Steultjens37e39 þþþ(HK) 0 0 0 0 (HK) (HK) 0
Stratford7,8,10 0 0 0 0 0 þþþ(HK) 0 0
FAS32e34 0 0 þ(HK) 0 0 þ(HK)y ? 0
þ(HK)z
þþþ or  strong evidence, þþ or moderate evidence, þ or  limited evidence,  conﬂicting evidence, ? unknown, 0 no information [þ ¼ positive,  negative rating
(results)], (H) ¼ hip, (K) ¼ Knee, (HK) ¼ Hip and Knee.
* Physiotherapy/exercise.
y Structural validity.
z Criterion validity.
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evidence for a selected few measures was established across
multiplemeasurement properties. This provides useful information
for clinicians and researchers about which performance-based
measures are currently the most suitable for assessing people
with hip and/or knee OA.
Similar to a previous review3, the current review identiﬁed
a variety of performance-based measures that represented several
different activity domains. For example, in this review, 10 different
variations of the walking test were identiﬁed. As such, we found it
useful to group the measures under three main activity themes: (1)
walking tests; (2) sit to stand tests; and (3) stair negotiation tests.
An additional group, multi-activity measures, contains different
variations and combinations of the three activity domains as well as
some additional domains such as getting in/out of a car35 and lift
and carrying tasks35,37e39.
Walking tests
Walking tests with the best measurement evidence included the
40 m self-paced walk test for hip OA30 and the 50ft (15.2 m) fast-
paced walk test for hip/knee OA23. Evidence for other walk tests
such as the 6-minwalk test has yet to be determined in people with
hip and/or knee OA.
Sit to stand tests
Sit to stand tests with the best measurement evidence included
the 30 s-chair stand test and the timed up and go test for hip/knee
OA6,23,30. Evidence for the ﬁve-repetition chair stand test has yet tobe determined. Based on current levels of evidence, the get up and
go test27 is not recommended for use in people with either hip or
knee OA.
Stair negotiation tests
Evidence for most variations of stair tests has yet to be deter-
mined. Only evidence of construct validity was reported for the 12-
step stair test for knee OA6. Given the current limited evidence of
stair negotiation tests, recommendations about which tests might
be more useful cannot be made.
Multi-activity measures
Multi-activity measures with the best measurement evidence
were the PAR35, the Stratford battery7,8,10 and the FAS32e34. In
addition, the PAR provided a good justiﬁcation for the choice of
included activities which consisted of a walking test (6-min walk
test), a stair negotiation test (ﬁve or nine-stair ascent/decent), a lift
and carry test and a car test. Based on current levels of evidence, the
Steultjens battery is not recommended for hip and knee OA38,39.
Evidence for the aggregated locomotor function (ALF) and Lin test is
yet to be determined.
A number of factors inﬂuenced the evidence found in the
review. The COSMIN quality scoring system developed for self-
reported questionnaires was modiﬁed to enable smaller studies
that were otherwise of acceptable quality, to be included in best
evidence synthesis. This change inﬂuenced the ﬁndings of the
majority of the reliability studies. Without this change, there would
have been no evidence for reliability for any of the measures
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tained from a single study as the majority of results could not be
combined because of the large variations in the testing procedures.
Further, for most multi-activity tests included in this review, there
was no information about the measurement model (reﬂective or
formative) in the development of the tests, nor in the validation
studies. Therefore it is difﬁcult to tell how important internal
consistency is for these tests. For some of the included tests, that
were based on a formative model, where the activities deﬁne the
construct (causal indicators) internal consistency may not be
relevant15.
There were some limitations to this review. Publication bias
from unpublished studies may threaten the internal validity as
unpublished studies are more likely to report negative or unfav-
ourable results. The decision to exclude measures that used
sophisticated equipment or measured constructs other than those
deﬁned as ‘Activities’ according to the ICF4 (i.e., balance measures)
meant that evidence for these types of measures was not included
in the review. In addition, further evidence may have been found
from some potentially good studies that fell short of the 80% OA
sample criteria40e46. We found considerable variations in the
performance-based measures which meant most evidence from
multiple studies of a measure could not be combined. Stronger
evidence may have been found if a larger number of more similar
studies were available.
This review highlights a number of areas worthy of future
research. More studies of the responsiveness and clinically MIC of
performance-based measures for people with hip and knee OA are
required. Although there is growing evidence for some of the
performance measures included in this review, no test has been
evaluated with respect to all measurement properties. On balance
of the evidence, the 40 m self-paced test30 was the best rated walk
test, the 30 s-chair stand test30 and timed up and go test30 were the
best rated sit to stand tests, and the PAR35, Stratford battery7,8,10,
and FAS32e34 were the best rated multi-activity measures. Addi-
tionally, before strong recommendations can be made, consensus is
still required on which variation of an activity theme is best and
what combination of tests would best assess physical function in
people with hip and/or knee OA. Extensive variation in types of
outcomes measures has been found across trials5,47, making
comparisons across studies and synthesis of results difﬁcult9. We
agree with recommendations that future work should be directed
at whether consensus can be achieved towards a standardised set
of performance-based outcome measures3,5,9.
Conclusion
This systematic review highlighted current gaps in our knowl-
edge of evidence about the measurement properties of
performance-based measures of physical function in people with
hip and/or knee OA. Further good quality research investigating the
measurement properties, and in particular the responsiveness and
interpretability of performance-basedmeasures, in people with hip
and/or knee OA is needed. Consensus on which combination of
measures will best assess physical function in hip/and or knee OA is
urgently required.
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Appendix 1. Search strategy
Filter 1: Construct terms
(“physical function*”[tw] OR “motor activity”[MH] OR “physical
activity”[tw] OR “physical activities”[tw] OR “physical perform-
ance*”[tw] OR “functional activity”[tw] OR “functional activi-
ties”[tw] OR “functional performance*”[tw] OR “activity
limitation*”[tw] OR “functional limitation*”[tw] OR disability[Title/
Abstract] OR disabilities[Title/Abstract] OR “Activities of daily
living”[MH]).
Filter 2: Target population
(“osteoarthritis”[MH]) OR osteoarthritis[Title/Abstract] OR
“arthritis”[MH]) OR arthritis[Title/Abstract]) OR (replacement
[Title/Abstract] OR arthroplasty[Title/Abstract]) AND (hip[Title/
Abstract] OR knee[Title/Abstract] OR “lower limb”[Title/Abstract]).
Filter 3: Instrument terms
(“physical performance measure*”[tw] OR “performance
test*”[tw] OR “performance-based test”[tw] OR “performance-
based tests”[tw] OR “performance based test*”[tw] OR “perfor-
mance measure*”[tw] OR “performance-based measure”[tw] OR
“performance-based measures”[tw] OR “performance instru-
ment*”[Title/Abstract] OR “performance-based instrument”[Title/
Abstract] OR “performance-based instruments”[Title/Abstract] OR
“performance-based method”[Title/Abstract] OR “performance-
based methods”[Title/Abstract] OR “performance based meth-
od*”[Title/Abstract] OR “performance index”[Title/Abstract] OR
“performance indices”[Title/Abstract] OR “performance-based
index”[Title/Abstract] OR “performance-based indices”[Title/
Abstract] OR “performance-based assessment”[Title/Abstract] OR
“performance-based assessments”[Title/Abstract] OR “objective
test*”[Title/Abstract] OR “objective instrument*”[Title/Abstract] OR
“objective method*”[Title/Abstract] OR “objective measure*”[Title/
Abstract] OR “objective evaluation*”[Title/Abstract] OR “objective
function*”[Title/Abstract] OR “objective disability”[Title/Abstract]
OR “objective assessment*”[Title/Abstract] OR “observational
Level Rating* Criteria
Strong þþþ or  Consistent ﬁndings in multiple studies
of good
Methodological quality OR in one study
of excellent
Methodological quality
Moderate þþ or  Consistent ﬁndings in multiple studies of fair
Methodological quality OR in one study of good
Methodological quality
Limited þ or  One study of fair methodological quality
Conﬂicting  Conﬂicting ﬁndings
Unknown ? Only studies of poor methodological quality
Adapted from Terwee et al. J Clin Epidemiol 2007;60(1):34e42.
* þ ¼ positive rating, ? ¼ indeterminate rating,  ¼ negative rating.
F. Dobson et al. / Osteoarthritis and Cartilage 20 (2012) 1548e15621560test*”[Title/Abstract] OR “observational-based test”[Title/Abstract]
OR “observational-based tests”[Title/Abstract] OR “observational
testing”[Title/Abstract] OR “observational instrument*”[Title/
Abstract] OR “observational-based instrument”[Title/Abstract] OR
“observational-based instruments”[Title/Abstract] OR “observa-
tional method*”[Title/Abstract] OR “observational-based meth-
od”[Title/Abstract] OR “observational-based methods”[Title/
Abstract] OR “observational measure*”[Title/Abstract] OR “obser-
vational-based measure”[Title/Abstract] OR “observational-based
measures”[Title/Abstract] OR “observational index”[Title/Abstract]
OR “observational indices”[Title/Abstract] OR “observation-based
index”[Title/Abstract] OR “observation-based indices”[Title/
Abstract] OR “observed disability”[Title/Abstract] OR “observed
function”[Title/Abstract] OR “gait analysis”[Title/Abstract] OR “gait
evaluation”[Title/Abstract] OR “walk* test”[Title/Abstract] OR “task
performance and analysis”[MH] OR Outcome Assessment[MH]).
Filter 4: Sensitive search ﬁlter for measurement properties
(instrumentation[sh] OR methods[sh] OR validation studies[pt]
OR Comparative Study[pt] OR psychometrics[MH] OR psychometr*
[tiab] OR clinimetr*[tw] OR clinometr*[tw] OR “outcome assess-
ment (health care)”[MH] OR “outcome assessment”[tiab] OR
“outcome measure*”[tw] OR “observer variation”[MH] OR
“observer variation”[tiab] OR “Health Status Indicators”[MH]
OR “reproducibility of results”[MH] OR reproducib*[tiab] OR
“discriminant analysis”[MH] OR reliab*[tiab] OR unreliab*[tiab] OR
valid*[tiab] OR coefﬁcient[tiab] OR homogeneity[tiab] OR homo-
geneous[tiab] OR “internal consistency”[tiab] OR (cronbach*[tiab]
AND (alpha[tiab] OR alphas[tiab])) OR (item[tiab] AND (correla-
tion*[tiab] OR selection*[tiab] OR reduction*[tiab])) OR agreement
[tiab] OR precision[tiab] OR imprecision[tiab] OR “precise value-
s”[tiab] OR testeretest[tiab] OR (test[tiab] AND retest[tiab]) OR
(reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR stability[tiab] OR
interrater[tiab] OR inter-rater[tiab] OR intrarater[tiab] OR intra-
rater[tiab] OR intertester[tiab] OR inter-tester[tiab] OR intratester
[tiab] OR intra-tester[tiab] OR interobserver[tiab] OR inter-observer
[tiab] OR intraobserver[tiab] OR intraobserver[tiab] OR inter-
technician[tiab] OR inter-technician[tiab] OR intratechnician[tiab]
OR intra-technician[tiab] OR interexaminer[tiab] OR inter-
examiner[tiab] OR intraexaminer[tiab] OR intra-examiner[tiab]
OR interassay[tiab] OR inter-assay[tiab] OR intraassay[tiab] OR
intra-assay[tiab] OR interindividual[tiab] OR inter-individual[tiab]
OR intraindividual[tiab] OR intra-individual[tiab] OR inter-
participant[tiab] OR inter-participant[tiab] OR intraparticipant
[tiab] OR intra-participant[tiab] OR kappa[tiab] OR kappa’s[tiab] OR
kappas[tiab] OR repeatab*[tiab] OR ((replicab*[tiab] OR repeated
[tiab]) AND (measure[tiab] OR measures[tiab] OR ﬁndings[tiab] OR
result[tiab] OR results[tiab] OR test[tiab] OR tests[tiab])) OR gen-
eraliza*[tiab] OR generalisa*[tiab] OR concordance[tiab] OR (intra-
class[tiab] AND correlation*[tiab]) OR discriminative[tiab] OR
“known group”[tiab] OR factor analysis[tiab] OR factor analyses
[tiab] OR dimension*[tiab] OR subscale*[tiab] OR (multitrait[tiab]
AND scaling[tiab] AND (analysis[tiab] OR analyses[tiab])) OR item
discriminant[tiab] OR interscale correlation*[tiab] OR error[tiab]
OR errors[tiab] OR “individual variability”[tiab] OR (variability[tiab]
AND (analysis[tiab] OR values[tiab])) OR (uncertainty[tiab] AND
(measurement[tiab] OR measuring[tiab])) OR “standard error of
measurement”[tiab] OR sensitiv*[tiab] OR responsive*[tiab] OR
((minimal[tiab] OR minimally[tiab] OR clinical[tiab] OR clinically
[tiab]) AND (important[tiab] OR signiﬁcant[tiab] OR detectable
[tiab])AND (change[tiab] OR difference[tiab])) OR (small*[tiab] AND
(real[tiab] OR detectable[tiab]) AND (change[tiab] OR difference
[tiab])) OR meaningful change[tiab] OR “ceiling effect”[tiab] OR
“ﬂoor effect”[tiab] OR “Item response model”[tiab] OR IRT[tiab] ORRasch[tiab] OR “Differential item functioning”[tiab] OR DIF[tiab] OR
“computer adaptive testing”[tiab] OR “item bank”[tiab] OR “cross-
cultural equivalence”[tiab]).
Filter 5: Exclusion ﬁlter
(“addresses”[PT] OR “biography”[PT] OR “case reports”[PT] OR
“comment”[PT] OR “directory”[PT] OR “editorial”[PT] OR “fes-
tschrift”[PT] OR “interview”[PT] OR “lectures”[PT] OR ”legal
cases”[PT] OR “legislation”[PT] OR “letter”[PT] OR “news”[PT] OR
“newspaper article”[PT] OR “patient education handout”[PT] OR
“popular works”[PT] OR “congresses”[PT] OR “consensus develop-
ment conference”[PT] OR “consensus development conference,
nih”[PT] OR “practice guideline”[Publication Type]) NOT (“animal-
s”[MeSH Terms] NOT “humans”[MeSH Terms]).
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